The Valley Desk

ArticleJPGN reportsPublished

Tirzepatide use in adolescents with metabolic dysfunction-associated steatotic liver disease (MASLD): A case series

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Children’s Hospital of Philadelphia. Affiliation source

Publication record

Type
Article
Venue
JPGN reports
Published
Subject terms
Pediatric Obesity; Dual Agonist; Gastric Inhibitory Peptide (Gip); Metabolic Dysfunction‐associated Steatohepatitis (Mash); Glucagon‐Like Peptide 1 Receptor Agonist (Glp‐1 Ra)
PubMed ID
42865987
PubMed Central ID
PMC13656291
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal